Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein.

Multidrug resistance due to P-glycoprotein is a serious impediment to successful chemotherapy of cancer. Numerous compounds are known that inhibit the drug-exporting function of P-glycoprotein. Understanding the mechanisms of action of these chemosensitizers is made difficult by the complexity of the in vivo cell systems usually employed. To examine the direct effects of chemosensitizers, we have developed a system in which purified and reconstituted P-glycoprotein transports. Hoechst 33342 from the lipid membrane to the aqueous interior of proteoliposomes, requiring ATP hydrolysis (Shapiro AB and Ling V, J Biol Chem 270: 16167-16175, 1995). Here, we use this system to understand the effect on P-glycoprotein of quercetin, one of three flavonoids that have been reported to have the unique property of stimulating drug transport by P-glycoprotein in vivo (Phang et al., Cancer Res 53: 5977-5981, 1993). Since flavonoids are abundant in food, it is important to understand their effects on the function of P-glycoprotein because of the implications for cancer chemotherapy. In our hands, quercetin inhibited P-glycoprotein-mediated Hoechst 33342 efflux and enhanced accumulation, as measured by flow cytometry, by multidrug-resistant CHRC5 cells. In the purified system, quercetin strongly inhibited Hoechst 33342 transport by P-glycoprotein, at least in part by inhibiting the ATPase activity of P-glycoprotein required for transport. We conclude that the previously reported stimulatory effect of quercetin on drug efflux from multidrug-resistant cells is not a direct effect on P-glycoprotein. The ATPase domain of P-glycoprotein may be an attractive target for new chemosensitizing agents.

[1]  R G Miller,et al.  Hoechst 33342 dye uptake as a probe of membrane permeability changes in mammalian cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[2]  A. Bodley,et al.  A new mammalian DNA topoisomerase I poison Hoechst 33342: cytotoxicity and drug resistance in human cell cultures. , 1993, Cancer research.

[3]  V. Ling,et al.  Modulation of ATP and drug binding by monoclonal antibodies against P‐glycoprotein , 1991, Journal of cellular physiology.

[4]  J. Endicott,et al.  The biochemistry of P-glycoprotein-mediated multidrug resistance. , 1989, Annual review of biochemistry.

[5]  J. Till,et al.  Pleiotropic phenotype of colchicine‐resistant CHO cells: Cross‐resistance and collateral sensitivity , 1976, Journal of cellular physiology.

[6]  J. Riordan,et al.  Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines , 1985, Nature.

[7]  F. Sharom,et al.  Functional reconstitution of drug transport and ATPase activity in proteoliposomes containing partially purified P-glycoprotein. , 1993, The Journal of biological chemistry.

[8]  J. Baak,et al.  Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells. , 1993, British Journal of Cancer.

[9]  P. Gros,et al.  Functional expression of P-glycoprotein encoded by the mouse mdr3 gene in yeast cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[10]  V. Ling,et al.  Reconstitution of Drug Transport by Purified P-glycoprotein (*) , 1995, The Journal of Biological Chemistry.

[11]  H. Ogawara,et al.  Use and specificity of genistein as inhibitor of protein-tyrosine kinases. , 1991, Methods in enzymology.

[12]  W. Bors,et al.  Flavonoids as antioxidants: determination of radical-scavenging efficiencies. , 1990, Methods in enzymology.

[13]  G. C. Yeh,et al.  Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism. , 1994, Biochemical pharmacology.

[14]  J. Lakowicz.  Principles of fluorescence spectroscopy , 1983 .

[15]  V. Ling,et al.  The MDR superfamily of genes and its biological implications. , 1994, Important advances in oncology.

[16]  I. Pastan,et al.  Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.

[17]  G. F. Ames,et al.  ATP-dependent transport systems in bacteria and humans: relevance to cystic fibrosis and multidrug resistance. , 1993, Annual review of microbiology.

[18]  G. C. Yeh,et al.  Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug-resistant breast cancer cells. , 1993, Cancer research.

[19]  M. Chiesi,et al.  Inhibition of constitutive endothelial NO-synthase activity by tannin and quercetin. , 1995, Biochemical pharmacology.

[20]  A. Shisheva,et al.  Quercetin selectively inhibits insulin receptor function in vitro and the bioresponses of insulin and insulinomimetic agents in rat adipocytes. , 1992, Biochemistry.

[21]  I. Tamai,et al.  Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells. , 1991, The Journal of biological chemistry.

[22]  V. Ling,et al.  Reduced permeability in CHO cells as a mechanism of resistance to colchicine , 1974, Journal of cellular physiology.

[23]  G. Elia,et al.  Regulation of heat shock protein synthesis by quercetin in human erythroleukaemia cells. , 1994, The Biochemical journal.

[24]  R L Juliano,et al.  A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.

[25]  V. Ling,et al.  ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells. , 1994, The Journal of biological chemistry.

[26]  S. Rosenberg,et al.  Important advances in oncology 1986 , 1994 .

[27]  C. Higgins,et al.  ABC transporters: from microorganisms to man. , 1992, Annual review of cell biology.